Progressive Ataxia and Cognitive Impairment Associated With SEZ6L2: Serum Neurofilament Light Chain as a Biomarker of Disease Activity
AE can mimic neurodegenerative processes, and SEZ6L2 antibody testing should be considered in patients with progressive ataxia and limbic involvement, even when no additional clues point towards an autoimmune etiology.